AJR Get Involved! Great Benefits! Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorbach, C.
Right arrow Articles by Boos, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorbach, C.
Right arrow Articles by Boos, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.04.1042
AJR 2006; 186:1228-1233
© American Roentgen Ray Society


Original Research

Therapeutic Efficacy of Facet Joint Blocks

Christoph Gorbach1, Marius R. Schmid2, Achim Elfering3, Juerg Hodler2 and Norbert Boos1

1 Center for Spinal Surgery, University of Zurich, University Hospital Balgrist, Zurich, Switzerland.
2 Department of Radiology, University Hospital Balgrist, Forchstrasse 340, CH-8008 Zurich, Switzerland.
3 Department of Psychology, University of Berne, Berne, Switzerland.

Received June 30, 2004; accepted after revision March 7, 2005.

 
Address correspondence to M. R. Schmid.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The objective of our study was to investigate outcome predictors of short- and medium-term therapeutic efficacy of facet joint blocks.

MATERIALS AND METHODS. Forty-two patients with chronic lower back pain who were undergoing facet joint blocks at one (n = 29) or two (n = 13) levels were analyzed. All patients underwent MRI or CT of the lumbar spine within 5 months before the facet joint blocks. The facet joint blocks were performed under fluoroscopic guidance. A small amount (< 0.3 mL) of iodinated contrast agent, 0.5 mL of local anesthetics and 0.5 mL of steroids, were injected. The initial pain response was prospectively assessed using a visual analogue scale. Additional data, including short-term effect (> 1 week) and medium-term effect (> 3 months), were collected by a structured telephone interview. CT and MRI were reviewed with regard to the extent of facet joint abnormalities. Multiple logistic regression analyses were conducted to identify outcome predictor for efficacy of facet joint blocks.

RESULTS. A positive immediate effect was seen in 31 patients (74%). A positive medium-term effect was found in 14 patients (33%). Pain alleviated by motion (p = 0.035) and the absence of joint-blocking sensation (p = 0.042) predicted pain relief. However, the extent of facet joint osteoarthritis on MRI and CT was not a significant predictor for outcome (p = 0.57-0.95).

CONCLUSION. Facet joint blocks appear to have a beneficial medium-term effect in one third of patients with chronic lower back pain and may therefore be a reasonable adjunct to nonoperative treatment. However, outcome appears to depend on clinical, not on morphologic, imaging findings.

Keywords: fluoroscopy • interventional radiology • musculoskeletal imaging • pain • spine


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Anumber of anatomic structures of the lumbar spine have been considered as the origin of lower back pain [1-5]. The significance of the lumbar facet in this context has been debated since the beginning of the last century [6]. Several authors have investigated pain patterns by injecting lumbar facet joints with hypertonic saline or by surgical stimulation [1, 2, 4, 5, 7]. Several studies have shown that the diagnosis of facet syndrome may be based on pain relief after intraarticular facet joint injection [8-11] or on provocation of pain by hypertonic saline injection followed by pain relief after injection of anesthetics [12]. This issue was debated in a study about diagnostic facet joint blocks in which the authors reported a false-positive rate of 38% and a positive predictive value of only 31% [13]. The diagnostic effect of facet joint block may be confounded by leakage of anesthetics into the periarticular structures [14-16].

The therapeutic efficacy of facet joint block in facet syndrome has not been as extensively evaluated as its diagnostic performance. Immediate pain reduction has been shown after injection of methylprednisolone and a placebo (saline) in 76% and 79% of injections, respectively [17]; however, after a follow-up period of 6 months, differences in pain relief (46% vs 15%, respectively) were found [17]. No outcome differences between intraarticular and periarticular injection of local anesthetics and methylprednisolone or saline injection were found [18, 19]. The authors of a literature review stated that there was no convincing evidence for the therapeutic efficacy of facet joint blocks in patients with lower back pain [20].

At our institution, facet joint blocks are routinely used to support nonoperative treatment for chronic lower back pain presumably due to symptomatic facet joint osteoarthritis. Our anecdotal perception is that a considerable proportion of patients report substantial pain relief after this procedure. However, there is a paucity of studies exploring the prediction of the therapeutic efficacy of a facet joint block. Selecting patients with chronic lower back pain who would benefit from a facet joint block would save health care costs.

The objective of this study was therefore to investigate outcome predictors of the short- and medium-term therapeutic efficacy of facet joint blocks.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Patients
All patients who underwent a lumbar facet joint block and who had either MRI or CT of the lumbar spine performed within 5 months before or after the injection were included in the study. The diagnosis of facet syndrome was based on the clinical presentation: lower back pain with or without radiation into the buttocks, thigh, or inguinal canal; increased pain on hyperextension; morning stiffness; and pain when starting to move [21-24]. The diagnosis of a facet syndrome was made by a staff spinal surgeon before a referral to the radiologist for the injection. The treating physician also decided on the levels to infiltrate. Exclusion criteria were the presence of radicular leg pain; a neurologic deficit; spinal surgery before the facet joint block; neoplasm; infection; and insufficient knowledge of the language predominantly spoken at the involved institution.

A total of 42 consecutive patients (32 women, 10 men; mean age, 61 years; age range, 39-88 years) who met these criteria were included in our investigation. Forty of the 42 patients presented with chronic lower back pain of more than 2 years' duration. The remaining two patients reported chronic (i.e., > 6 months' duration) lower back pain for a duration of less than 2 years. Twenty-nine patients had single-level facet joint blocks that were performed unilaterally in eight and bilaterally in 21 patients, respectively. In 13 patients, the facet joint block was performed bilaterally at two levels.

The target facet joints and sides were selected on the basis of clinical presentation and the presence of facet joint osteoarthritis according to previously published criteria that are valid for both CT and MRI [25].

The hospital's review board allows this type of retrospective study to be performed based on a general permit issued by the responsible state agency. Informed consent was obtained from all patients who fulfilled our inclusion and exclusion criteria.

Imaging Technique
All MR examinations were performed on a 1.0-T system (Expert, Siemens Medical Solutions) with a dedicated receive-only spine coil. The imaging protocol consisted of a sagittal T1-weighted spin-echo sequence (TR/TE, 700/12; section thickness, 4 mm; intersection gap, 0.8 mm; field of view, 300 mm; matrix, 512 x 512; 4 acquisitions), a T2-weighted turbo spin-echo sequence (5,000/130; section thickness, 4 mm; intersection gap, 0.8 mm; echo-train length, 15; 4 acquisitions), and an axial T2-weighted turbo spin-echo sequence (4,000/96; section thickness, 4 mm; intersection gap, 0.8 mm; field of view, 300 mm; matrix, 512 x 512; echo-train length, 7; 2 acquisitions). CT scans were obtained using a single-detector helical CT unit (Somatom Plus 4, Siemens Medical Solutions). The imaging parameters were 2-mm slice thickness, 2.5-mm table feed, and a reconstruction increment of 2 mm.

Injection Technique
The technique we used is a modification of the one described by Bogduk et al. [9]. All injections were performed in our musculoskeletal radiology department either by an experienced staff radiologist or by a radiology fellow. The facet joint blocks were performed under fluoroscopic guidance with the patient lying prone. To visualize the lumbar joints, either the patient was rotated appropriately and supported in an oblique prone position or the image intensifier and tube were tilted accordingly. Most commonly, a lateral-to-medial angulation of between 30° and 40° was necessary. In cases of L5-S1 facet joint block, additional craniocaudal angulation was used to avoid a conflict of the needle track with the iliac crest.

After appropriate disinfection, the skin over the target joint was anesthetized with 2-3 mL of mepivacaine 2% (Scandicain, AstraZeneca). A 22-gauge spinal needle was then inserted parallel to the X-ray beam, aiming at the joint space. In heavy patients, a coaxial needle technique was used, in which a 22-gauge needle was passed through a shorter 18-gauge needle. Depending on the specific situation (anatomic factors, presence or absence of osteophytes), either the midpoint or rather the cranial or caudal part of the joint was targeted. A minimal quantity of contrast medium (< 0.3 mL) was then injected under fluoroscopy to confirm the correct needle position (Fig. 1). Needle placement and contrast distribution were documented on standard radiographs.


Figure 1
View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 —Documentation of fluoroscopic injection. 70-year-old woman with grade 2 degeneration of right L4-L5 facet joint. One needle (curved arrow) is placed in right L3-L4 facet joint. Contrast material has not yet been injected. Second needle (large straight arrow) is placed in right L4-L5 right facet joint. Thin line of contrast material is visible within joint space (small straight arrows) with filling of inferior and superior joint recesses (arrowheads).

 
Subsequently, a mixture of 0.5-1.0 mL of local anesthetics (bupivacaine 0.5% [Carbostesin, Astra-Zeneca] or mepivacaine 2%) and 0.5 mL of steroids (20 mg of triamcinolone [Kenacort, Bristol-Myers Squibb]) was injected. The patients were kept under surveillance for at least 15 min after termination of the facet joint block.

Measured Variables and Data Management
The patients were routinely followed up in the spine outpatient clinic, typically 3-4 weeks after injection (mean, 23.7 days; range, 1-77 days). Based on a chart review, five different domains were related to outcome—that is, sociodemographic, general health indicators, clinical presentation, technical aspects, and facet joint morphology. The initial (15-30 min) pain response was prospectively collected using a visual analogue scale. For immediate-term response analysis, we asked patients to score the degree of pain reduction in relation to the pain level before the facet joint block. We did not ask patients to provide a baseline visual analogue scale score before injection.

Additional data were obtained by a structured telephone interview to complete the data from the chart review. Besides patient age, sex, and marital status, the following general health indicators were asked: general life satisfaction, general health, and whether the patient smokes. In addition, patients were asked about 17 clinical variables including the first episode and the number of episodes of lower back pain, maximum pain level, influence of different provocation movements, pain alleviation by motion, and joint-blocking sensation ("lumbar catch"). The interviewer of the structured telephone interview was aware of the facet joint block treatment without specific knowledge about the degree of facet joint degeneration. The following outcome variables were considered: pain reduction 15-30 min after injection (immediate effect); pain reduction for more than 1 week (short-term effect); and pain reduction for more than 3 months (medium-term effect). Responders were defined as those who reported a reduction in pain of more than 50%.

The imaging studies (CT and MRI) were reviewed by a musculoskeletal radiologist with regard to the extent of facet joint abnormalities. The following grading system was used (Figs. 2, 3, 4, 5): grade 0, normal width of the facet joint space (2-4 mm); grade 1, narrowing of the facet joint space (< 2 mm), small osteophytes, or mild hypertrophy of the articular process; grade 2, narrowing of the facet joint space, moderate osteophytes, moderate hypertrophy of the articular process, or mild subarticular bone erosions; and grade 3, narrowing of the facet joint space, large osteophytes, severe hypertrophy of the articular process, severe subarticular bone erosions, or subchondral cysts. The grading of facet joint osteoarthritis was based on the width of the facet joint space and the presence of osteophytes, articular process hypertrophy, subchondral bone erosions, and subchondral cysts [25]. Such assessment has been reported to be reliable, with good interobserver agreement ({kappa} = 0.60) [25]. Because there is good agreement between MRI and CT with regard to facet joint osteoarthritis [25], imaging findings were not separately assessed for these two imaging methods.


Figure 2
View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 —Bilateral grade 0 facet joint osteoarthritis. 48-year-old woman with normal (grade 0) facet joints at L5-S1 level. T2-weighted axial MR image (TR/TE, 4,000/96) shows thin, well-demarcated hyperintense line (straight arrows), presumably caused by combination of intraarticular fluid and superficial parts of articular cartilage. Hypointense line (curved arrows), in part, represents subchondral bone and deep layers of articular cartilage. Findings suggestive of subchondral sclerosis, osteophytes, and cysts are absent.

 

Figure 3
View larger version (118K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 —Bilateral grade 1 facet joint osteoarthritis. 51-year-old woman with grade 1 facet joint degeneration on both sides at L4-L5 level. Axial T2-weighted MR image (TR/TE, 4,000/96) depicts almost no visible cartilage (arrows). Beginning facet joint hypertrophy (arrowheads) can be seen on left side.

 

Figure 4
View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 —Grade 2 facet joint osteoarthritis on right side. 51-year-old woman with grade 2 osteoarthritis of right facet joint at L5-S1 level. Axial T2-weighted MR image (TR/TE, 4,000/96) shows joint space narrowing, subchondral sclerosis (curved arrows), and small cyst formation (straight arrow), indicating moderate facet joint degeneration.

 

Figure 5
View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 —Grade 3 facet joint osteoarthritis on right side. 64-year-old woman with severe bilateral L3-L4 facet joint degeneration. T2-weighed axial MR image (TR/TE 4,000/96) shows facet joint hypertrophy with osteophytes (large straight arrows), subchondral erosions (curved arrow), and hypertrophy of ligamentum flavum (small straight arrows).

 

Statistical Analysis
For each outcome variable (i.e., immediate, short-term, and medium-term effects) the population was divided into responders and nonresponders (responders, > 50% pain reduction on the visual analogue scale). A blockwise multiple logistic regression analysis, including a forward inclusion criterion within each block of variables, was conducted to identify predictor variables. All analyses were controlled for the effects of patient age and sex (Table 1). The significance of the differences between radiologic grades of osteoarthritis, immediate effect, medium-term effect, and the duration of facet joint block were calculated using Fisher's exact test (expected cell values were < 5 in more than 20% of cells in most analyses, which prevented the use of the chi-square test and analysis of variance). The statistical procedures were performed with SPSS software (version 11.0, Statistical Package for the Social Sciences). Unless stated otherwise, the level of statistical significance was set at 0.05 (two-tailed). Statistical tendencies (p < 0.10) were also reported to identify all potential predictor variables that might prove to be significant only in a larger patient population.


View this table:
[in this window]
[in a new window]

 
TABLE 1: Prediction (Logistic Regression Analyses) of Outcome Variables

 


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The mean follow-up period was 17 months (range, 6-34 months). None of the patients reported any adverse reaction after the intervention.

Thirty-one patients (74%) experienced immediate pain reduction of more than 50%, eight of whom (19%) had complete disappearance of pain. After 1 week, 24 patients (57%) were still experiencing a pain reduction of more than 50%. The eight initially pain-free patients remained asymptomatic after 1 week. After 3 months (medium-term effect), pain relief of more than 50% persisted in 14 patients (33%). Eleven patients (26%) experienced no relevant immediate, short-term, or medium-term pain relief. After 7 days, three subjects who initially experienced no decrease in pain at all reported pain relief of between 20% and 45% that lasted up to 30 days.

There was no significant relationship between sociodemographic factors and positive response to a facet joint block (Table 1). Patients who were smokers were somewhat less likely to respond immediately to a facet joint block (p = 0.06). This tendency was more pronounced at short-term follow-up (p = 0.039). Patients in good general health were more likely to respond well after short-term follow-up (p = 0.054). Pain that was alleviated by motion was a positive predictor for a good immediate response (p = 0.035). Such pain was associated with higher grades of osteoarthritis (odds ratio = 9.27, p = 0.01, confidence interval = 1.70-50.60). Patients without joint-blocking sensations had a higher chance to respond at medium-term follow-up (p = 0.042).

If only the patients without the symptom of pain decreasing with motion had been injected, 52% (16 of 31) of patients instead of 67% (whole study group) would have been responders in the immediate term. This group showed no difference in medium-term outcome. If only the patients with the symptom of absence of joint-blocking sensation had been injected, 45% (9 of 20) of patients instead of 33% (whole study group) would have been responders in the medium term. When patients with absence of joint-blocking sensation and without pain decreasing with motion were selected (only four patients fulfilled these criteria), 75% and 100% would have been responders in the immediate and medium terms, respectively.

There was no significant immediate and medium-term difference between maximum and average grades of facet joint osteoarthritis (Table 2 and Figs. 6A, 6B, 7A, and 7B). Although patients with radiologic grade 1 facet joint osteoarthritis showed a shorter mean duration of pain decrease (86 days) compared with those with grades 2 (120 days) and 3 (117 days), this difference was not statistically significant (p = 0.69). In 28 cases, all injections were intraarticular, and in four cases only a periarticular injection was possible. In the remaining patients, a mixed intraarticular-periarticular injection of the selected joint was performed.


View this table:
[in this window]
[in a new window]

 
TABLE 2: Radiologic Grading of Osteoarthritis and Immediate and Medium-Term Effects

 

Figure 6
View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A —69-year-old woman patient with bilateral grade 1 osteoarthritis at L4-L5 level and lower back pain radiating from back to both thighs. No substantial pain relief after facet joint block. Axial T2-weighted MR image shows minimal medial narrowing of joint space (small arrow) and facet joint hypertrophy (large arrow) on left, indicating grade 1 facet joint degeneration.

 

Figure 7
View larger version (102K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B —69-year-old woman patient with bilateral grade 1 osteoarthritis at L4-L5 level and lower back pain radiating from back to both thighs. No substantial pain relief after facet joint block. Arthrography image obtained after intraarticular injection of contrast material within joint space (arrow) and within inferior and superior articular recesses (arrowheads).

 

Figure 8
View larger version (101K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7A —51-year-old woman with bilateral L4-L5 facet joint degeneration. She had been experiencing lower back pain for more than 5 years. Bilateral L4-L5 facet joint block resulted in pain relief of 100% for more than 3 months. Patient has grade 2 facet osteoarthritis that is responding well to facet joint block. CT image shows moderate bilateral osteophytes (white arrows) and small subchondral cysts on left side (black arrows).

 

Figure 9
View larger version (82K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7B —51-year-old woman with bilateral L4-L5 facet joint degeneration. She had been experiencing lower back pain for more than 5 years. Bilateral L4-L5 facet joint block resulted in pain relief of 100% for more than 3 months. Patient has grade 2 facet osteoarthritis that is responding well to facet joint block. Arthrography image obtained after intraarticular injection of contrast material within joint space (arrow) and within inferior and superior articular recess (arrowheads).

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
In a review, Nelemans et al. [20] concluded that there is no convincing evidence for the therapeutic efficacy of facet joint block in the treatment of lower back pain. However, based on our anecdotal experience, a substantial number of patients benefit from facet joint block in the medium term. In our study group, 33% of patients responded well (> 50% pain relief) after 3 months. These results are in line with previously published investigations about the therapeutic effect of facet joint blocks [1, 17]. Admittedly, the precise mechanism of such effect is not known. Lilius et al. [18, 19] found comparable effects after placebo (saline) and methylprednisolone injections. In addition, even the relatively small injection volumes used at our institution are probably too large to remain completely contained within the small facet joints. In previously published investigations, larger volumes have been used than that used in our standard protocol. The expected leakage of infiltrated substances may lead to confounding effects, such as blocking of the nerve roots or their branches. However, independent of the underlying mechanisms, facet joint blocks result in considerable pain relief (> 50% pain reduction for more than 3 months in 33% of patients) in patients with chronic lower back pain and can be applied without any adverse effects.

To limit the facet joint blocks to a population with a positive medium-term therapeutic effect, outcome predictors after facet joint block are important. Interestingly, facet joint degeneration as diagnosed on either CT or MR images was not a predictor. No statistically significant difference in the medium-term effect between low- and high-grade facet joint osteoarthritis could be found in our investigation. However, patients with pain alleviation on motion and higher grades of osteoarthritis were more likely to respond immediately, indicating a correlation to symptomatic facet joint osteoarthritis. We also noted that patients without joint-blocking sensations had a higher chance to respond at medium-term follow-up (p = 0.042). A joint-blocking sensation is reported by the patient as a sudden catch in the back that resolves again after a few movements. Joint-blocking sensations can be interpreted as a clinical sign of instability. In this context, patients with that finding appear to respond less consistently to facet joint blocks because pain is not originating only from the facet joints.

If only patients with pain decreasing with motion and without joint-blocking sensation were injected, immediate and medium-term success (> 50% pain decrease) would have been achieved in 75% and 100% of patients, respectively. Only four patients in our study group fulfilled both criteria, and this combined evaluation of symptoms was statistically not significant.

Our study and previously published investigations have attempted to relate several clinical signs to the outcome of facet joint block. Jackson [26] and Jackson et al. [27] concluded that there were no such findings predicting injection response. Revel et al. [28] reported several predictor variables (i.e., age > 65 years, pain not exacerbated by coughing, not worsened by hyperextension, not worsened by forward flexion, not worsened when rising from flexion, not worsened by extension-rotation, and well relieved by recumbency) for a positive effect to lidocaine facet joint blocks. Our results showed different clinical predictor variables— decreasing pain during motion and absence of joint-blocking sensation—that seem to be related to a good facet joint block response. These results have a fairly high sensitivity (94%) but a low specificity (55%). Furthermore, there is a statistical trend for good general health (p = 0.054) to be predictive for a positive response and for smoking (p = 0.060) to be predictive for a negative response to a facet joint block.

We acknowledge the following study limitations. The retrospective pain assessment may decrease the reproducibility and validity of our results. Moreover, there was no control group receiving a placebo treatment. However, the presence and extent of the placebo effect have to be taken into account when discussing the efficacy of facet joint blocks [29]. In addition, it is unlikely that the natural history of lower back pain would positively influence the course in our patient group because of the fact that all but two patients had lower back pain for more than 2 years. In patients with chronic lower back pain [30, 31], natural history is unlikely to have a positive influence anymore.

This study shows a beneficial medium-term effect (> 3 months) in one third of patients with chronic lower back pain and facet joint blocks may therefore be a reasonable adjunct to nonoperative treatment. However, outcome appears to depend on clinical, not on morphologic imaging, findings. Further exploration of the therapeutic efficacy—particularly with regard to cost-effectiveness—is required to determine more conclusively the value of facet joint blocks in patients with lower back pain.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Mooney V, Robertson J. The facet syndrome. Clin Orthop 1976; 115:149 -156
  2. Kellgren JH. On the distribution of pain arising from deep somatic structures with charts of segmental pain areas. Clin Sci 1938; 4:35 -46
  3. Kellgren JH. Observations on referred pain arising from muscle. Clin Sci 1938; 3:175 -190
  4. Hockaday JM, Whitty CW. Patterns of referred pain in the normal subject. Brain 1967;90 : 481-496[Free Full Text]
  5. Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am 1991; 22:181 -187[Medline]
  6. Ghormley RK. Low back pain: with special reference to the articular facets, with presentation of an operative procedure. JAMA 1933; 101:1773 -1777
  7. McCall IW, Park WM, O'Brien JP. Induced pain referral from posterior lumbar elements in normal subjects. Spine1979; 4:441 -446[CrossRef][Medline]
  8. Marks RC, Houston T, Thulbourne T. Facet joint injection and facet nerve block: a randomised comparison in 86 patients with chronic low back pain. Pain 1992;49 : 325-328[CrossRef][Medline]
  9. Bogduk N, Aprill C, Derby R. Lumbar zygapophyseal joint pain: diagnostic blocks and therapy. In: Wilson DJ, ed. Practical interventional radiology of the musculoskeletal system. Oxford, UK: University of Oxford Press, 1995:73 -86
  10. Carrera GF. Lumbar facet joint injection in low back pain and sciatica: preliminary results. Radiology1980; 137:665 -667[Abstract/Free Full Text]
  11. Lippitt AB. The facet joint and its role in spine pain: management with facet joint injections. Spine 1984;9 : 746-750[CrossRef][Medline]
  12. Moran R, O'Connell D, Walsh MG. The diagnostic value of facet joint injections. Spine 1988;13 : 1407-1410[CrossRef][Medline]
  13. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The false-positive rate of uncontrolled diagnostic blocks of the lumbar zygapophysial joints. Pain 1994;58 : 195-200[CrossRef][Medline]
  14. Raymond J, Dumas JM. Intraarticular facet block: diagnostic test or therapeutic procedure? Radiology 1984;151 : 333-336[Abstract/Free Full Text]
  15. Dory MA. Arthrography of the lumbar facet joints. Radiology 1981;140 : 23-27[Abstract/Free Full Text]
  16. Maldague B, Mathurin P, Malghem J. Facet joint arthrography in lumbar spondylolysis. Radiology 1981;140 : 29-36[Abstract/Free Full Text]
  17. Carette S, Marcoux S, Truchon R, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 1991;325 : 1002-1007[Abstract]
  18. Lilius G, Laasonen EM, Myllynen P, Harilainen A, Gronlund G. Lumbar facet joint syndrome: a randomized clinical trial. J Bone Joint Surg Br 1989; 71:681 -684
  19. Lilius G, Harilainen A, Laasonen EM, Myllynen P. Chronic unilateral low-back pain: predictors of outcome of facet joint injections. Spine 1990; 15:780 -782[CrossRef][Medline]
  20. Nelemans PJ, deBie RA, deVet HC, Sturmans F. Injection therapy for subacute and chronic benign low back pain. Spine2001; 26:501 -515[CrossRef][Medline]
  21. Kirkaldy-Willis WH, Burton CV. The three phases of the spectrum of degenerative disease. In: Kirkaldy-Willis WH, Burton CV, eds. Managing low back pain. New York, NY: Churchill Livingstone, 1992: 105-110
  22. Gatterman MI, Panzer D. Disorders of the lumbar spine. In: Pine JW, ed. Chiropractic management of spine related disorders. Baltimore, MD: Williams & Wilkins,1990 : 129-175
  23. Schulitz KP, Lenz G. Das Facettensyndrom-Klinik und Therapie. In: Hohmann D, Kuegelgen B, Liebig K, eds. Neuroorthopädie 2 Lendenwirbelsäulenerkrankungen mit Beteiligung des Nervensystems. Berlin, Germany: Springer, 1984:543 -550
  24. Laros GS. Differential diagnosis of low back pain. In: Mayer TG, Mooney V, Gatchel RJ, eds. Contemporary conservative care for painful spinal disorders. Philadelphia, PA: Lea & Febiger,1991 : 122-130
  25. Weishaupt D, Zanetti M, Boos N, Hodler J. MR imaging and CT in osteoarthritis of the lumbar facet joints. Skeletal Radiol 1999; 28:215 -219[CrossRef][Medline]
  26. Jackson RP. The facet syndrome: myth or reality? Clin Orthop 1992; 279:110 -121
  27. Jackson RP, Jacobs RR, Montesano PX. Facet joint infection in low-back pain: a prospective statistical study. Spine1988; 13:966 -971[CrossRef][Medline]
  28. Revel ME, Listrat VM, Chevalier XJ, et al. Facet joint block for low back pain: identifying predictors of a good response. Arch Phys Med Rehabil 1992; 73:824 -828[Medline]
  29. Hrobjartsson A. The uncontrollable placebo effect. Eur J Clin Pharmacol 1996; 50:345 -348[Medline]
  30. Klenerman L, Slade PD, Stanley IM, et al. The prediction of chronicity in patients with an acute attack of low back pain in a general practice setting. Spine 1995;20 : 478-484[Medline]
  31. Von Korff M, Deyo RA, Cherkin D, Barlow W. Back pain in primary care: outcomes at 1 year. Spine. 1993;18 : 855-862[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorbach, C.
Right arrow Articles by Boos, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorbach, C.
Right arrow Articles by Boos, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS